Abstract:Background: Branch atheromatous disease (BAD) is a primary cause of early neurological deterioration (END) in penetrating artery occlusion, leading to poor functional outcomes. While it has been proposed to classify BAD under large artery atherosclerosis, uncertainty exists regarding the optimal treatment strategy, including cholesterol-lowering targets. Objectives: We aimed to assess the clinical implications and temporal changes of atherosclerotic plaques before and after high-intensity statin treatment. Design: This is a high-resolution vessel-wall imaging sub-analysis of the trial of Statin and Dual Antiplatelet Therapy in Preventing Early Neurological Deterioration in Branch Atheromatous Disease (SATBRAD). Methods: In this prospective, single-group cohort study, participants in the treatment arm of the SATBRAD trial received early dual antiplatelet therapy and high-intensity statin treatment. The majority of these participants subsequently underwent high-resolution vessel-wall magnetic resonance imaging (MRI). Those with atheromatous plaques in the parent artery continued high-intensity statin treatment for 6 months, followed by a repeat MRI to monitor plaque changes. Results: There were 57 patients who underwent vessel-wall imaging and 24 exhibited contrast-enhanced plaques. Patients with contrast-enhanced plaques showed higher rates of END (29.2% vs 6.1%, p = 0.027), perfusion defects (62.5% vs 24.2%, p = 0.004), and lower rates of good outcomes at 3 months (50.0% vs 81.8%, p = 0.011). After adjusting for confounding factors, contrast-enhanced plaque had a negative impact on achieving a good outcome at 3 months (adjusted odds ratio = 0.04; 95% confidence interval = <0.01–0.60). Following high-intensity statin treatment in 36 patients, there was a notable reduction in stenosis (33.7% vs 29.3%, p = 0.005) and contrast-enhanced plaque volume (16.3 vs 11.6 mm 3 , p = 0.015). Conclusion: The study highlighted the association between contrast-enhanced atherosclerotic plaques, END, and poor functional outcomes, with high-intensity treatment leading to plaque volume reduction. These results underscore the shared pathology between BAD and intracranial atherosclerosis, emphasizing the necessity for further research and tailored treatment strategies for BAD. Trial registration: ClinicalTrials.gov; Identifier: NCT04824911 ( https://clinicaltrials.gov/study/NCT04824911 ).

Abstract 16783: Risk Factors Associated with Progression of Carotid Wall Volume and Plaque Lipid Content in Patients with Established Vascular Disease and Treated with Intensive Lipid Therapy in the AIM-HIGH Study

Associations among Carotid Plaque Progression, Cerebrovascular/ Cardiovascular Diseases and LDL-C/non-HDL-C Goal Achievement in Diabetic Patients: A Retrospective Cohort Study

Abstract 5092: Effects of Intensive Lipid Therapy on Atherosclerotic Plaque Burden and Time-course: A Prospective, Randomized, Double Blinded Study With Magnetic Resonance Imaging (MRI)

Magnetic Resonance Imaging of Intraplaque Hemorrhage and Plaque Lipid Content With Continued Lipid-Lowering Therapy: Results of a Magnetic Resonance Imaging Substudy in AIM-HIGH

Carotid Artery Atherosclerosis: Effect Of Intensive Lipid Therapy On The Vasa Vasorum-Evaluation By Using Dynamic Contrast-Enhanced Mr Imaging

Longer Duration of Statin Therapy is Associated with Decreased Carotid Plaque Vascularity by Magnetic Resonance Imaging.

Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides Impact on Global Health Ou

Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology

Subclinical carotid atherosclerosis: short-term natural history of lipid-rich necrotic core--a multicenter study with MR imaging.

Abstract WP416: Risk Factors for Symmetrical Distribution of Carotid Atherosclerotic High-risk Plaque Determined by Black-blood, High Resolution Magnetic Resonance Imaging

Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging

Discriminating Carotid Atherosclerotic Lesion Severity by Luminal Stenosis and Plaque Burden

Abstract 274: in Vivo Assessment of Adventitial Vasa Vasorum in Patients with Symptomatic Carotid Plaques: A Dynamic Contrast-Enhanced MR Imaging Study

Summary of Clinical and Laboratory Data of Study Subjects with and Without DCE-MRI Plaque Measurements in the AIM-HIGH Clinical Trial.

Preliminary results on temporal evolution and clinical implications of atherosclerotic plaque in branch atheromatous disease after statin treatment

Long-Term Carotid Plaque Progression and the Role of Intraplaque Hemorrhage: Analysis from Deep Learning-based Longitudinal Vessel Wall Imaging

Association Between Changes in Perivascular Adipose Tissue Density and Plaque Progression

Discriminating Carotid Atherosclerotic Lesion Severity By Luminal Stenosis And Plaque Burden A Comparison Utilizing High-Resolution Magnetic Resonance Imaging At 3.0 Tesla

Factors Associated with High-Risk Plaque Characteristics Among Patients with Medium to Severe Carotid Artery Stenosis

Time-efficient patient-specific quantification of regional carotid artery fluid dynamics and spatial correlation with plaque burden

Carotid Geometry and Wall Shear Stress Independently Predict Increased Wall Thickness—A Longitudinal 3D MRI Study in High-Risk Patients